SEC Form 3 · accession 0001104659-18-057854
Y-mAbs Therapeutics, Inc. · YMAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Torben Lund-Hansen
Officer — Sr. VP and Head of Tech Op
Period of report
Sep 20, 2018
Accepted (ET)
Sep 20, 2018 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001722964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 45,662 | I | By Toluha ApS |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $4.38 | holding | — | — | — | — | May 20, 2026 | Common Stock | 150,000 | — | D |
Explanation of responses
- F1Reporting Person is sole member of Toluha ApS.
- F2The stock option vested and became exercisable as to 25% of the shares subject to the option on May 20, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.